inert 1 MG Oral Tablet
- RxCUI
- 748797
- RxNorm name
- inert 1 MG Oral Tablet
- Display name
- inert 1 MG Oral Tablet
- Full name
- inert 1 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| norgestimate and ethinyl estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | PD-Rx Pharmaceuticals, Inc. | 2385591b-70ee-0577-e063-6394a90a9357 | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | 748797 |
| desogestrel and ethinyl estradiol and ethinyl estradiol | DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | Apotex Corp. | 5a179f7b-a718-494f-8c97-ece34f356ca7 | 2026-06-30 | Warnings, Adverse reactions | 748797 |
| Desogestrel and Ethinyl Estradiol | DESOGESTREL AND ETHINYL ESTRADIOL | Camber Pharmaceuticals, Inc. | 78454ebf-f1a3-4ca0-b32e-88c51bc57773 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 748797 |
| VIORELE | DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | A-S Medication Solutions | 6422dcc3-959a-4590-9ca8-9dcb58e68253 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 748797 |
| MONO-LINYAH | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 2ec8f18f-297c-405f-b191-a40767366bad | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Turqoz | NORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | e7a05138-91a5-4c66-a915-614576e0805a | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Kurvelo | LEVONORGESTREL AND ETHINYL ESTRADIOL | Lupin Pharmaceuticals, Inc. | 752f525e-1838-4058-9ab7-2c2d91f86dfd | 2026-05-20 | Boxed warning, Warnings | 748797 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | DROSPIRENONE AND ETHINYL ESTRADIOL | Apotex Corp. | 9187a357-e95d-4733-9627-f19522b86373 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Wera | NORETHINDRONE AND ETHINYL ESTRADIOL | Northstar Rx LLC | 638e4f36-1a27-4220-8ec9-3fa9d9b36c11 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Dasetta 7/7/7 | NORETHINDRONE AND ETHINYL ESTRADIOL | Northstar Rx LLC | da52e74a-1baf-4a33-a068-b49176700320 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Levonorgestrel and Ethinyl Estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Apotex Corp. | a7a1fb54-5a24-40ff-b862-dea256309b7d | 2026-04-04 | Warnings, Adverse reactions | 748797 |
| Levonorgestrel and Ethinyl Estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Apotex Corp. | 18c143b6-2f83-4dcb-b84a-855739212f25 | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Vestura | DROSPIRENONE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals, Inc. | c6f63cc0-11b0-4320-a9ef-5bd5c9b16fd5 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Cryselle | NORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | f73ece43-6b5f-4abb-ba6d-4d62775f2f8e | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 35c6507c-555a-45ed-aaf6-8695831de71a | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| VIENVA TM | LEVONORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | f6825c1a-ba78-47aa-9622-12e59517ab1a | 2026-03-03 | Warnings, Adverse reactions | 748797 |
| drospirenone and ethinyl estradiol | DROSPIRENONE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 6edead7f-a41f-4d0b-a27a-b2047ed4eea0 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Lutera | LEVONORGESTREL AND ETHINYL ESTRADIOL | Dr. Reddys Laboratories Inc. | 47fc432b-2259-47d2-bba9-5e3aae583990 | 2026-02-13 | Warnings, Adverse reactions | 748797 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 8b247e46-203e-4f5b-b5a7-cbd57341c735 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | 748797 |
| BRIELLYN | NORETHINDRONE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | c0e2c5b4-70ac-4b41-aa71-00e506dbb72f | 2026-01-31 | Warnings, Adverse reactions | 748797 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 4a8f278f-f505-4537-8deb-74e8927df8c6 | inert ingredients 1 MG Oral Tablet | SCD | 104 | Isibloom TM (Desogestrel and Ethinyl Estradiol Tablets, USP) 0.15 mg/0.03 mg Rx only | 20240925 |
| 4a8f278f-f505-4537-8deb-74e8927df8c6 | inert 1 MG Oral Tablet | PSN | 104 | Isibloom TM (Desogestrel and Ethinyl Estradiol Tablets, USP) 0.15 mg/0.03 mg Rx only | 20240925 |
| e0b07fb6-8dbd-4e5d-b589-5191a1dc02ae | inert 1 MG Oral Tablet | PSN | 104 | These highlights do not include all the information needed to use Estarylla™ safely and effectively. See full prescribing information for Estarylla™. Estarylla™ (NORGESTIMATE and ETHINYL ESTRADIOL tablets) for oral use Initial U.S. Approval: 1989 | 20240924 |
| e0b07fb6-8dbd-4e5d-b589-5191a1dc02ae | inert ingredients 1 MG Oral Tablet | SCD | 104 | These highlights do not include all the information needed to use Estarylla™ safely and effectively. See full prescribing information for Estarylla™. Estarylla™ (NORGESTIMATE and ETHINYL ESTRADIOL tablets) for oral use Initial U.S. Approval: 1989 | 20240924 |
| 6560d15f-6ce9-4f0e-9b59-043dec35ddd9 | inert ingredients 1 MG Oral Tablet | SCD | 104 | These highlights do not include all the information needed to use Tri-Estarylla safely and effectively. See full prescribing information for Tri-Estarylla. Tri-Estarylla ® (norgestimate and ethinyl estradiol, USP) tablets, for oral use Initial U.S. Approval: 1989 | 20240521 |
| 6560d15f-6ce9-4f0e-9b59-043dec35ddd9 | inert 1 MG Oral Tablet | PSN | 104 | These highlights do not include all the information needed to use Tri-Estarylla safely and effectively. See full prescribing information for Tri-Estarylla. Tri-Estarylla ® (norgestimate and ethinyl estradiol, USP) tablets, for oral use Initial U.S. Approval: 1989 | 20240521 |
| 90f7ab24-7839-4408-9a74-07bb6a79eacc | inert 1 MG Oral Tablet | PSN | 104 | These highlights do not include all the information needed to use Tri-Lo-Estarylla safely and effectively. See full prescribing information for Tri-Lo-Estarylla. Tri-Lo-Estarylla ® (norgestimate and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 1989 | 20240521 |
| 90f7ab24-7839-4408-9a74-07bb6a79eacc | inert ingredients 1 MG Oral Tablet | SCD | 104 | These highlights do not include all the information needed to use Tri-Lo-Estarylla safely and effectively. See full prescribing information for Tri-Lo-Estarylla. Tri-Lo-Estarylla ® (norgestimate and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 1989 | 20240521 |
| 4424505f-acae-43ba-8a75-eadd0e283b23 | inert ingredients 1 MG Oral Tablet | SCD | 104 | These highlights do not include all the information needed to use SYEDA safely and effectively. See full prescribing information for SYEDA. SYEDA (drospirenone and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20240110 |
| 4424505f-acae-43ba-8a75-eadd0e283b23 | inert 1 MG Oral Tablet | PSN | 104 | These highlights do not include all the information needed to use SYEDA safely and effectively. See full prescribing information for SYEDA. SYEDA (drospirenone and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20240110 |
| ed92658d-87e3-4b5a-912f-0b51943da5e3 | inert 1 MG Oral Tablet | PSN | 104 | These highlights do not include all the information needed to use Loryna (drospirenone and ethinyl estradiol tablets) safely and effectively. See full prescribing information for Loryna (drospirenone and ethinyl estradiol tablets). Loryna ® (Drospirenone and Ethinyl Estradiol Tablets, USP) 3 mg/0.02 mg, for oral use Initial U.S. Approval: 2001 | 20240110 |
| ed92658d-87e3-4b5a-912f-0b51943da5e3 | inert ingredients 1 MG Oral Tablet | SCD | 104 | These highlights do not include all the information needed to use Loryna (drospirenone and ethinyl estradiol tablets) safely and effectively. See full prescribing information for Loryna (drospirenone and ethinyl estradiol tablets). Loryna ® (Drospirenone and Ethinyl Estradiol Tablets, USP) 3 mg/0.02 mg, for oral use Initial U.S. Approval: 2001 | 20240110 |
| 0e65209d-329a-4d31-8afb-24348dc8d7e7 | inert 1 MG Oral Tablet | PSN | 103 | Volnea™ (Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP) | 20240111 |
| 0e65209d-329a-4d31-8afb-24348dc8d7e7 | inert ingredients 1 MG Oral Tablet | SCD | 103 | Volnea™ (Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP) | 20240111 |
| c607816d-0da9-4960-9723-69f28aa3f2f2 | inert ingredients 1 MG Oral Tablet | SCD | 103 | ALTAVERA TM Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg and 0.03 mg Rx only | 20230302 |
| c607816d-0da9-4960-9723-69f28aa3f2f2 | inert 1 MG Oral Tablet | PSN | 103 | ALTAVERA TM Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg and 0.03 mg Rx only | 20230302 |
| 0d729f4d-2fa3-47f6-8a1f-d8cfea4cff37 | inert ingredients 1 MG Oral Tablet | SCD | 28 | These highlights do not include all the information needed to use OCELLA safely and effectively. See full prescribing information for OCELLA. OCELLA (drospirenone/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20260304 |
| 0d729f4d-2fa3-47f6-8a1f-d8cfea4cff37 | inert 1 MG Oral Tablet | PSN | 28 | These highlights do not include all the information needed to use OCELLA safely and effectively. See full prescribing information for OCELLA. OCELLA (drospirenone/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20260304 |
| 3448d121-d00a-4752-8782-416b7a376f3f | inert 1 MG Oral Tablet | PSN | 23 | APRI 28 DAY | 20240612 |
| 3448d121-d00a-4752-8782-416b7a376f3f | inert ingredients 1 MG Oral Tablet | SCD | 23 | APRI 28 DAY | 20240612 |
| 065f33e4-b587-4e66-b896-ca9ab7b7c876 | inert ingredients 1 MG Oral Tablet | SCD | 21 | These highlights do not include all the information needed to use YAZ safely and effectively. See full prescribing information for YAZ. YAZ® (drospirenone/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20250529 |
| 065f33e4-b587-4e66-b896-ca9ab7b7c876 | inert 1 MG Oral Tablet | PSN | 21 | These highlights do not include all the information needed to use YAZ safely and effectively. See full prescribing information for YAZ. YAZ® (drospirenone/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20250529 |
| d7ea6a60-5a56-4f81-b206-9b27b7e58875 | inert ingredients 1 MG Oral Tablet | SCD | 21 | These highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20230519 |
| d7ea6a60-5a56-4f81-b206-9b27b7e58875 | inert 1 MG Oral Tablet | PSN | 21 | These highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20230519 |
| dfda3568-b626-4194-b0af-df5d2ea69e3f | inert ingredients 1 MG Oral Tablet | SCD | 20 | LEVONEST (Levonorgestrel and Ethinyl Estradiol Tablets USP, Triphasic Regimen) | 20231003 |
| dfda3568-b626-4194-b0af-df5d2ea69e3f | inert 1 MG Oral Tablet | PSN | 20 | LEVONEST (Levonorgestrel and Ethinyl Estradiol Tablets USP, Triphasic Regimen) | 20231003 |
| 27178b07-42bd-496d-aebb-d9428664ee72 | inert ingredients 1 MG Oral Tablet | SCD | 19 | Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/30 mcg Rx only | 20220731 |
| 27178b07-42bd-496d-aebb-d9428664ee72 | inert 1 MG Oral Tablet | PSN | 19 | Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/30 mcg Rx only | 20220731 |
| 58e85e02-93e7-42ba-b8f5-a36290c68423 | inert ingredients 1 MG Oral Tablet | SCD | 18 | These highlights do not include all the information needed to use levonorgestrel and ethinyl estradiol tablets safely and effectively. See full prescribing information for levonorgestrel and ethinyl estradiol tablets. LEVONORGESTREL and ETHINYL ESTRADIOL tablets for oral use Initial U.S. Approval: 1982 | 20251113 |
| 58e85e02-93e7-42ba-b8f5-a36290c68423 | inert 1 MG Oral Tablet | PSN | 18 | These highlights do not include all the information needed to use levonorgestrel and ethinyl estradiol tablets safely and effectively. See full prescribing information for levonorgestrel and ethinyl estradiol tablets. LEVONORGESTREL and ETHINYL ESTRADIOL tablets for oral use Initial U.S. Approval: 1982 | 20251113 |
| f1076019-6f2c-4c90-9f3c-ab0c7cdd9315 | inert ingredients 1 MG Oral Tablet | SCD | 18 | These highlights do not include all the information needed to use JOLESSA safely and effectively. See full prescribing information for JOLESSA . JOLESSA ® (levonorgestrel and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 1982 | 20241024 |
| f1076019-6f2c-4c90-9f3c-ab0c7cdd9315 | inert 1 MG Oral Tablet | PSN | 18 | These highlights do not include all the information needed to use JOLESSA safely and effectively. See full prescribing information for JOLESSA . JOLESSA ® (levonorgestrel and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 1982 | 20241024 |
| 9b1f944b-b05b-4ab0-bcf6-42f426b07c45 | inert ingredients 1 MG Oral Tablet | SCD | 18 | These highlights do not include all the information needed to use DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS. DROSPIRENONE AND ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 2001 | 20240507 |
| 9b1f944b-b05b-4ab0-bcf6-42f426b07c45 | inert 1 MG Oral Tablet | PSN | 18 | These highlights do not include all the information needed to use DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS. DROSPIRENONE AND ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 2001 | 20240507 |
| 992dcc56-90ab-4691-8114-16d47a8b9982 | inert ingredients 1 MG Oral Tablet | SCD | 18 | Nortrel ® 7/7/7 (norethindrone and ethinyl estradiol tablets USP, 0.5/0.035 mg, 0.75/0.035 mg, and 1/0.035 mg) | 20211201 |
| 992dcc56-90ab-4691-8114-16d47a8b9982 | inert 1 MG Oral Tablet | PSN | 18 | Nortrel ® 7/7/7 (norethindrone and ethinyl estradiol tablets USP, 0.5/0.035 mg, 0.75/0.035 mg, and 1/0.035 mg) | 20211201 |
| 8b247e46-203e-4f5b-b5a7-cbd57341c735 | inert ingredients 1 MG Oral Tablet | SCD | 17 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20260206 |
| 8b247e46-203e-4f5b-b5a7-cbd57341c735 | inert 1 MG Oral Tablet | PSN | 17 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20260206 |
| 39988aa6-8f68-40e8-9bdd-c40a3bdaad61 | inert ingredients 1 MG Oral Tablet | SCD | 17 | VIORELE ® (Desogestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.02 mg and Ethinyl Estradiol Tablets, USP 0.01 mg) Rx only | 20260131 |
| 39988aa6-8f68-40e8-9bdd-c40a3bdaad61 | inert 1 MG Oral Tablet | PSN | 17 | VIORELE ® (Desogestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.02 mg and Ethinyl Estradiol Tablets, USP 0.01 mg) Rx only | 20260131 |
| 843cbef6-cbfb-4a44-bb80-22930753e4c0 | inert 1 MG Oral Tablet | PSN | 17 | These highlights do not include all the information needed to use TRI-SPRINTEC ® safely and effectively. See full prescribing information for TRI-SPRINTEC ® . TRI-SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20250312 |
| 843cbef6-cbfb-4a44-bb80-22930753e4c0 | inert ingredients 1 MG Oral Tablet | SCD | 17 | These highlights do not include all the information needed to use TRI-SPRINTEC ® safely and effectively. See full prescribing information for TRI-SPRINTEC ® . TRI-SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20250312 |
| 02c91fba-9c47-43ef-ac78-e82369798834 | inert ingredients 1 MG Oral Tablet | SCD | 17 | These highlights do not include all the information needed to use NATAZIA safely and effectively. See full prescribing information for NATAZIA. NATAZIA (estradiol valerate and estradiol valerate/dienogest) tablets for oral use Initial U.S. Approval: 2010 | 20240626 |
| 02c91fba-9c47-43ef-ac78-e82369798834 | inert 1 MG Oral Tablet | PSN | 17 | These highlights do not include all the information needed to use NATAZIA safely and effectively. See full prescribing information for NATAZIA. NATAZIA (estradiol valerate and estradiol valerate/dienogest) tablets for oral use Initial U.S. Approval: 2010 | 20240626 |
| 142c4b90-c9ab-45ce-9172-f1ea7d366686 | inert 1 MG Oral Tablet | PSN | 17 | Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP | 20230801 |
| 142c4b90-c9ab-45ce-9172-f1ea7d366686 | inert ingredients 1 MG Oral Tablet | SCD | 17 | Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP | 20230801 |
| 6422dcc3-959a-4590-9ca8-9dcb58e68253 | inert ingredients 1 MG Oral Tablet | SCD | 16 | VIORELE | 20240218 |
| 6422dcc3-959a-4590-9ca8-9dcb58e68253 | inert 1 MG Oral Tablet | PSN | 16 | VIORELE | 20240218 |
| 140c50d6-c931-423a-9aa0-526eae7ab93c | inert ingredients 1 MG Oral Tablet | SCD | 16 | Nortrel ® (norethindrone and ethinyl estradiol tablets USP) | 20211201 |
| 140c50d6-c931-423a-9aa0-526eae7ab93c | inert 1 MG Oral Tablet | PSN | 16 | Nortrel ® (norethindrone and ethinyl estradiol tablets USP) | 20211201 |
| 2385591b-70ee-0577-e063-6394a90a9357 | inert ingredients 1 MG Oral Tablet | SCD | 15 | These highlights do not include all the information needed to use TRI-LO-MARZIA safely and effectively. See full prescribing information for TRI-LO-MARZIA. TRI-LO-MARZIA™ (norgestimate and ethinyl estradiol tablets USP), for oral use Initial U.S. Approval: 1989 | 20250408 |
| 2385591b-70ee-0577-e063-6394a90a9357 | inert 1 MG Oral Tablet | PSN | 15 | These highlights do not include all the information needed to use TRI-LO-MARZIA safely and effectively. See full prescribing information for TRI-LO-MARZIA. TRI-LO-MARZIA™ (norgestimate and ethinyl estradiol tablets USP), for oral use Initial U.S. Approval: 1989 | 20250408 |
| c78b236b-85c4-4258-a524-cea08775100c | inert ingredients 1 MG Oral Tablet | SCD | 15 | Portia ® (levonorgestrel and ethinyl estradiol tablets USP) Rx only | 20250312 |
| c78b236b-85c4-4258-a524-cea08775100c | inert 1 MG Oral Tablet | PSN | 15 | Portia ® (levonorgestrel and ethinyl estradiol tablets USP) Rx only | 20250312 |
| 8f88b17a-5d0e-448a-8a60-f49c28ba6dfb | inert ingredients 1 MG Oral Tablet | SCD | 15 | Aviane ® 28 Tablets (levonorgestrel and ethinyl estradiol tablets USP) Rx only | 20240729 |
| 8f88b17a-5d0e-448a-8a60-f49c28ba6dfb | inert 1 MG Oral Tablet | PSN | 15 | Aviane ® 28 Tablets (levonorgestrel and ethinyl estradiol tablets USP) Rx only | 20240729 |
| fcf4f8ea-1eb3-4a43-87d2-16f93e904443 | inert ingredients 1 MG Oral Tablet | SCD | 15 | Cryselle ® (norgestrel and ethinyl estradiol tablets USP) | 20240507 |
| fcf4f8ea-1eb3-4a43-87d2-16f93e904443 | inert 1 MG Oral Tablet | PSN | 15 | Cryselle ® (norgestrel and ethinyl estradiol tablets USP) | 20240507 |
| 7b11e11f-6977-4109-b9bd-a066e5d1278a | inert 1 MG Oral Tablet | PSN | 15 | Kariva ® (desogestrel/ethinyl estradiol and ethinyl estradiol tablets USP) Rx only | 20240326 |
| 7b11e11f-6977-4109-b9bd-a066e5d1278a | inert ingredients 1 MG Oral Tablet | SCD | 15 | Kariva ® (desogestrel/ethinyl estradiol and ethinyl estradiol tablets USP) Rx only | 20240326 |
| 4d888008-cc14-4291-b384-0d482f48eb08 | inert 1 MG Oral Tablet | PSN | 15 | These highlights do not include all the information needed to use TRI-LO-MARZIA safely and effectively. See full prescribing information for TRI-LO-MARZIA. TRI-LO-MARZIA™ (norgestimate and ethinyl estradiol tablets USP), for oral use Initial U.S. Approval: 1989 | 20240310 |
| 4d888008-cc14-4291-b384-0d482f48eb08 | inert ingredients 1 MG Oral Tablet | SCD | 15 | These highlights do not include all the information needed to use TRI-LO-MARZIA safely and effectively. See full prescribing information for TRI-LO-MARZIA. TRI-LO-MARZIA™ (norgestimate and ethinyl estradiol tablets USP), for oral use Initial U.S. Approval: 1989 | 20240310 |
| ee6be128-d494-4361-9a0d-341c0eee3587 | inert 1 MG Oral Tablet | PSN | 15 | Cryselle ® (norgestrel and ethinyl estradiol tablets USP) | 20220728 |
| ee6be128-d494-4361-9a0d-341c0eee3587 | inert ingredients 1 MG Oral Tablet | SCD | 15 | Cryselle ® (norgestrel and ethinyl estradiol tablets USP) | 20220728 |
| 36a282d2-7285-442b-9574-dfce2d9456f1 | inert 1 MG Oral Tablet | PSN | 15 | Balziva ® (norethindrone and ethinyl estradiol tablets USP ) | 20211231 |
| 36a282d2-7285-442b-9574-dfce2d9456f1 | inert ingredients 1 MG Oral Tablet | SCD | 15 | Balziva ® (norethindrone and ethinyl estradiol tablets USP ) | 20211231 |
| 638e4f36-1a27-4220-8ec9-3fa9d9b36c11 | inert 1 MG Oral Tablet | PSN | 14 | WERA TM (Norethindrone and Ethinyl Estradiol Tablets, USP) 0.5 mg/0.035 mg | 20260415 |
| 638e4f36-1a27-4220-8ec9-3fa9d9b36c11 | inert ingredients 1 MG Oral Tablet | SCD | 14 | WERA TM (Norethindrone and Ethinyl Estradiol Tablets, USP) 0.5 mg/0.035 mg | 20260415 |
| da52e74a-1baf-4a33-a068-b49176700320 | inert 1 MG Oral Tablet | PSN | 14 | DASETTATM 7/7/7 (norethindrone/ethinyl estradiol Tablets, USP) | 20260414 |
| da52e74a-1baf-4a33-a068-b49176700320 | inert ingredients 1 MG Oral Tablet | SCD | 14 | DASETTATM 7/7/7 (norethindrone/ethinyl estradiol Tablets, USP) | 20260414 |
| 9379d99e-c416-4dab-a817-1c110e0d4b93 | inert ingredients 1 MG Oral Tablet | SCD | 14 | MARLISSA ® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) | 20260129 |
| 9379d99e-c416-4dab-a817-1c110e0d4b93 | inert 1 MG Oral Tablet | PSN | 14 | MARLISSA ® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) | 20260129 |
| bc402baa-5de4-4149-9857-081a9b4eb280 | inert 1 MG Oral Tablet | PSN | 14 | These highlights do not include all the information needed to use TRI-LO-MARZIA safely and effectively. See full prescribing information for TRI-LO-MARZIA. TRI-LO-MARZIA™ (norgestimate and ethinyl estradiol tablets USP), for oral use Initial U.S. Approval: 1989 | 20251209 |
| bc402baa-5de4-4149-9857-081a9b4eb280 | inert ingredients 1 MG Oral Tablet | SCD | 14 | These highlights do not include all the information needed to use TRI-LO-MARZIA safely and effectively. See full prescribing information for TRI-LO-MARZIA. TRI-LO-MARZIA™ (norgestimate and ethinyl estradiol tablets USP), for oral use Initial U.S. Approval: 1989 | 20251209 |
| 2b54ce42-db64-46c3-a788-569e21f7ab06 | inert ingredients 1 MG Oral Tablet | SCD | 14 | Ayuna ® (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg) Rx only | 20250801 |
| 2b54ce42-db64-46c3-a788-569e21f7ab06 | inert 1 MG Oral Tablet | PSN | 14 | Ayuna ® (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg) Rx only | 20250801 |
| 8755b020-d439-4ba2-a60b-6c57a15ece55 | inert 1 MG Oral Tablet | PSN | 14 | Low-Ogestrel ® (Norgestrel and Ethinyl Estradiol Tablets USP, 0.3 mg/0.03 mg) | 20250728 |
| 8755b020-d439-4ba2-a60b-6c57a15ece55 | inert ingredients 1 MG Oral Tablet | SCD | 14 | Low-Ogestrel ® (Norgestrel and Ethinyl Estradiol Tablets USP, 0.3 mg/0.03 mg) | 20250728 |
| a45ee86e-69ca-49a5-8990-5dde52d4a522 | inert 1 MG Oral Tablet | PSN | 14 | ALYACEN 1/35 | 20240507 |
| a45ee86e-69ca-49a5-8990-5dde52d4a522 | inert ingredients 1 MG Oral Tablet | SCD | 14 | ALYACEN 1/35 | 20240507 |